Home Business Opioid Distributors Reach $ 518 Million with Washington State, Reuters reports

Opioid Distributors Reach $ 518 Million with Washington State, Reuters reports


© Reuters. PHOTO PHOTO: Opioid-based hydrocadone tablets at a pharmacy in Portsmouth, Ohio, June 21, 2017. REUTERS / Bryan Woolston / File Photo

Dietrich Knight

(Reuters) – Washington has reached a $ 518 million deal with drug dealers McKesson Corp (NYSE :), AmerisourceBergen (NYSE đŸ™‚ Corp and Drastic health (NYSE :), concluding a months-long lawsuit over the alleged role of companies in fueling the opioid epidemic in the state, announced three companies on Tuesday.

McKeson will pay $ 197 million, while AmerisourceBergen and the Cardinal will pay $ 160.5 million each.

Washington has abandoned a $ 26 billion nationwide opioid settlement involving three drug dealers and Johnson & Johnson (NYSE :). It would receive up to $ 417.9 million from McKesson, Cardinal Health and AmerisourceBergen under the settlement, which was completed in February.

The settlement is one of the largest in Washington state history, Washington Attorney General Bob Ferguson said in a press release.

“We could join the vast majority of states and agree with the largest opioid distributors, but instead we decided to fight them in court,” Ferguson said. “This decision to take them to court will lead to significant additional resources for Washington to combat the opioid epidemic.” The state accused drug dealers of failing to prevent the diversion of prescription pills for illegal use during a trial that began in November earlier. King County Supreme Court Judge Michael Scott is in Seattle. Washington has demanded $ 38.2 billion to fund treatment.

Distributors who deny the offense said the settlement would provide substantial assistance to communities affected by the opioid epidemic in the United States.

According to the U.S. Centers for Disease Control and Prevention, opioid overdoses have caused more than 500,000 deaths in the United States over the past two decades.

Washington was one of several states that abandoned the $ 26 billion national opioid settlement, along with Alabama and Oklahoma. New Hampshire settled with three drug dealers but not with J&J, while West Virginia was not part of a national agreement due to a preliminary settlement between the state and three drug dealers.

Recently, on April 18, Alabama reached a separate deal with McKesson, J&J and Endo International (NASDAQ đŸ™‚ Plc for $ 276 million, avoiding the lawsuit that was due to begin against McKesson that day.

On April 20, West Virginia granted the state’s $ 99 million opioid claim against J&J. West Virginia counties are still suing McKeson, AmerisourceBergen and Cardinal Health.

Trials against opioids against other defendants are currently underway in Florida and West Virginia. Florida is suing the Walgreens Boots Alliance (NASDAQ :), and West Virginia is suing Teva Pharmaceutical Industries (NYSE đŸ™‚ Ltd and AbbVie (NYSE đŸ™‚ Allergan (NYSE :).

Previous articleU.S. stocks are rising and bond yields are declining ahead of the Fed’s move
Next articleStates and advocacy groups are suing the USPS